Mukund Paravasthu, Chief Operating Officer at NovoCure Ltd (NVCR), sold 97,246 shares at $13.31 ($1.3M) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Open-market sale of $1.3M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.31 | 5,377 | $72K | 5.4% |
| 2 | $13.31 | 5,377 | $72K | 5.4% |
| 3 | $13.77 | 43,246 | $595K | 44.6% |
| 4 | $13.77 | 43,246 | $596K | 44.6% |
| Total | $13.72 avg | 97,246 | $1.3M | 100% |
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $40K | — | Filing → |
| NVCR | SELL | 2025-01-15 | $116K | — | Filing → |